Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong · Delayed Price · Currency is HKD 5.31
-0.07 (-1.30%)
Nov 21, 2025, 11:59 AM HKT
HKG:1066 Market Cap
HKG:1066 has a market cap or net worth of 24.46 billion as of November 20, 2025. Its market cap has increased by 7.01% in one year.
Market Cap
24.46B
Enterprise Value
21.66B
Revenue
14.35B
Ranking
n/a
PE Ratio
11.41
Stock Price
5.31
Market Cap Chart
Since February 27, 2004, HKG:1066's market cap has increased from 572.70M to 24.46B, an increase of 4,170.33%. That is a compound annual growth rate of 18.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 24.00B | 14.16% |
| Dec 31, 2024 | 21.02B | -39.55% |
| Dec 29, 2023 | 34.78B | -40.64% |
| Dec 30, 2022 | 58.60B | 33.16% |
| Dec 31, 2021 | 44.00B | -44.46% |
| Dec 31, 2020 | 79.23B | 87.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 323.98B |
| Hansoh Pharmaceutical Group Company | 238.40B |
| JD Health International | 222.18B |
| Innovent Biologics | 155.60B |
| WuXi Biologics | 132.76B |
| Sino Biopharmaceutical | 127.28B |
| Akeso | 107.04B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.44B |